|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Napier KJ, Scheerer M and Misra S:
Esophageal cancer: A review of epidemiology, pathogenesis, staging
workup and treatment modalities. World J Gastrointest Oncol.
6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brown LM, Devesa SS and Chow WH: Incidence
of adenocarcinoma of the esophagus among white americans by sex,
stage, and age. J Natl Cancer Inst. 100:1184–1187. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shaheen NJ and Richter JE: Barrett's
oesophagus. Lancet. 373:850–861. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hvid-Jensen F, Pedersen L, Drewes AM,
Sørensen HT and Funch-Jensen P: Incidence of adenocarcinoma among
patients with Barrett's esophagus. N Engl J Med. 365:1375–1383.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cameron AJ and Lomboy CT: Barrett's
esophagus: Age, prevalence, and extent of columnar epithelium.
Gastroenterology. 103:1241–1245. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wild CP and Hardie LJ: Reflux, Barrett's
oesophagus and adenocarcinoma: Burning questions. Nat Rev Cancer.
3:676–684. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ke XS, Liu CM, Liu DP and Liang CC:
MicroRNAs: Key participants in gene regulatory networks. Curr Opin
Chem Biol. 7:516–523. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nilsen TW: Mechanisms of microRNA-mediated
gene regulation in animal cells. Trends Genet. 23:243–249. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Melo SA and Esteller M: Dysregulation of
microRNAs in cancer: Playing with fire. FEBS Lett. 585:2087–2099.
2011. View Article : Google Scholar
|
|
11
|
Fassan M, Baffa R, Kiss A, Zaninotto G and
Rugge M: MicroRNA dysregulation in esophageal neoplasia: The
biological rationale for novel therapeutic options. Curr Pharm Des.
19:1236–1241. 2013.
|
|
12
|
Zhang B, Pan X, Cobb GP and Anderson TA:
MicroRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
13
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Suzuki H, Maruyama R, Yamamoto E and Kai
M: DNA methylation and microRNA dysregulation in cancer. Mol Oncol.
6:567–578. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Lin R and Li J: Epigenetic silencing
of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig
Dis Sci. 56:2849–2856. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cui X, Zhao Z, Liu D, Guo T, Li S, Hu J,
Liu C, Yang L, Cao Y, Jiang J, et al: Inactivation of miR-34a by
aberrant CpG methylation in Kazakh patients with esophageal
carcinoma. J Exp Clin Cancer Res. 33:202014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen J, Feilotter HE, Paré GC, Zhang X,
Pemberton JG, Garady C, Lai D, Yang X and Tron VA: MicroRNA-193b
represses cell proliferation and regulates cyclin D1 in melanoma.
Am J Pathol. 176:2520–2529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rauhala HE, Jalava SE, Isotalo J, Bracken
H, Lehmusvaara S, Tammela TL, Oja H and Visakorpi T: miR-193b is an
epigenetically regulated putative tumor suppressor in prostate
cancer. Int J Cancer. 127:1363–1372. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li XF, Yan PJ and Shao ZM: Downregulation
of miR-193b contributes to enhance urokinase-type plasminogen
activator (uPA) expression and tumor progression and invasion in
human breast cancer. Oncogene. 28:3937–3934. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(t)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
21
|
Huang YW, Kuo CT, Chen JH, Goodfellow PJ,
Huang TH, Rader JS and Uyar DS: Hypermethylation of miR-203 in
endometrial carcinomas. Gynecol Oncol. 133:340–345. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gastaldi C, Bertero T, Xu N,
Bourget-Ponzio I, Lebrigand K, Fourre S, Popa A, Cardot-Leccia N,
Meneguzzi G, Sonkoly E, et al: miR-193b/365a cluster controls
progression of epidermal squamous cell carcinoma. Carcinogenesis.
35:1110–1120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zang W, Wang Y, Du Y, Xuan X, Wang T, Li
M, Ma Y, Li P, Chen X, Dong Z and Zhao G: Differential expression
profiling of microRNAs and their potential involvement in
esophageal squamous cell carcinoma. Tumour Biol. 35:3295–3304.
2014. View Article : Google Scholar
|
|
24
|
Gao XN, Lin J, Gao L, Li YH, Wang LL and
Yu L: MicroRNA-193b regulates c-Kit proto-oncogene and represses
cell proliferation in acute myeloid leukemia. Leuk Res.
35:1226–1232. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu W, Lin Z, Zhuang Z and Liang X:
Expression profile of mammalian microRNAs in endometrioid
adenocarcinoma. Eur J Cancer Prev. 18:50–55. 2009. View Article : Google Scholar
|
|
26
|
Issa JP: CpG island methylator phenotype
in cancer. Nat Rev Cancer. 4:988–993. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Taylor BS, DeCarolis PL, Angeles CV,
Brenet F, Schultz N, Antonescu CR, Scandura JM, Sander C, Viale AJ,
Socci ND and Singer S: Frequent alterations and epigenetic
silencing of differentiation pathway genes in structurally
rearranged liposarcomas. Cancer Discov. 1:587–597. 2011. View Article : Google Scholar
|
|
28
|
Li J, Kong F, Wu K, Song K, He J and Sun
W: miR-193b directly targets STMN1 and uPA genes and suppresses
tumor growth and metastasis in pancreatic cancer. Mol Med Rep.
10:2613–2620. 2014.PubMed/NCBI
|
|
29
|
Xu C, Liu S, Fu H, Li S, Tie Y, Zhu J,
Xing R, Jin Y, Sun Z and Zheng X: MicroRNA-193b regulates
proliferation, migration and invasion in human hepatocellular
carcinoma cells. Eur J Cancer. 46:2828–2836. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lenarduzzi M, Hui AB, Alajez NM, Shi W,
Williams J, Yue S, O'Sullivan B and Liu FF: MicroRNA-193b enhances
tumor progression via down regulation of neurofibromin 1. PLoS One.
8:e537652013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kaukoniemi KM, Rauhala HE, Scaravilli M,
Latonen L, Annala M, Vessella RL, Nykter M, Tammela TL and
Visakorpi T: Epigenetically altered miR-193b targets cyclin D1 in
prostate cancer. Cancer Med. 4:1417–1425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mitra AK, Chiang CY, Tiwari P, Tomar S,
Watters KM, Peter ME and Lengyel E: Microenvironment-induced
downregulation of miR-193b drives ovarian cancer metastasis.
Oncogene. 34:5923–5932. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mets E, Van der Meulen J, Van Peer G,
Boice M, Mestdagh P, Van de Walle I, Lammens T, Goossens S, De
Moerloose B, Benoit Y, et al: MicroRNA-193b-3p acts as a tumor
suppressor by targeting the MYB oncogene in T-cell acute
lymphoblastic leukemia. Leukemia. 29:798–806. 2015. View Article : Google Scholar
|
|
34
|
Jin X, Sun Y, Yang H, Li J, Yu S, Chang X,
Lu Z and Chen J: Deregulation of the MiR-193b-KRAS Axis Contributes
to Impaired Cell Growth in Pancreatic Cancer. PLoS One.
10:e01255152015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhong Q, Wang T, Lu P, Zhang R, Zou J and
Yuan S: miR-193b promotes cell proliferation by targeting Smad3 in
human glioma. J Neurosci Res. 92:619–626. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Satoh J: Molecular network of microRNA
targets in Alzheimer's disease brains. Exp Neurol. 235:436–446.
2012. View Article : Google Scholar
|
|
37
|
Brink M, de Goeij AF, Weijenberg MP,
Roemen GM, Lentjes MH, Pachen MM, Smits KM, de Bruïne AP, Goldbohm
RA and van den Brandt PA: K-ras oncogene mutations in sporadic
colorectal cancer in The Netherlands Cohort Study. Carcinogenesis.
24:703–710. 2003. View Article : Google Scholar : PubMed/NCBI
|
